CD274 and neoplasm: A “hot” tumor with the high expression of PD–L1 and the enhanced infiltration of the cytotoxic T lymphocytes (CTLs) exhibits a sensitivity to the PD–L1 inhibitors and improves the prognosis of patients with anti–PD–L1 therapy.